EUR 15.88
(-0.75%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.64 Billion EUR | -3.08% |
2022 | 1.7 Billion EUR | -5.73% |
2021 | 1.8 Billion EUR | -13.11% |
2020 | 2.07 Billion EUR | -0.22% |
2019 | 2.08 Billion EUR | 26.8% |
2018 | 1.64 Billion EUR | 6.72% |
2017 | 1.53 Billion EUR | -0.02% |
2016 | 1.53 Billion EUR | 9.1% |
2015 | 1.41 Billion EUR | 9.51% |
2014 | 1.28 Billion EUR | 23.35% |
2013 | 1.04 Billion EUR | 0.56% |
2012 | 1.03 Billion EUR | -7.45% |
2011 | 1.12 Billion EUR | -12.17% |
2010 | 1.27 Billion EUR | -7.84% |
2009 | 1.38 Billion EUR | -36.82% |
2008 | 2.19 Billion EUR | 1.9% |
2007 | 2.15 Billion EUR | 0.09% |
2006 | 2.15 Billion EUR | 13.77% |
2005 | 1.89 Billion EUR | 59.23% |
2004 | 1.18 Billion EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.73 Billion EUR | 0.0% |
2023 FY | 1.64 Billion EUR | -3.08% |
2023 Q4 | 1.64 Billion EUR | 175.2% |
2023 Q2 | 1.74 Billion EUR | 179.47% |
2023 Q3 | -2.19 Billion EUR | -225.57% |
2023 Q1 | -2.19 Billion EUR | -229.16% |
2022 FY | 1.7 Billion EUR | -5.73% |
2022 Q2 | 1.68 Billion EUR | 0.0% |
2022 Q4 | 1.7 Billion EUR | 0.0% |
2021 Q4 | 1.8 Billion EUR | 300.0% |
2021 Q3 | 451.35 Million EUR | -79.0% |
2021 FY | 1.8 Billion EUR | -13.11% |
2021 Q1 | 451.35 Million EUR | -78.28% |
2021 Q2 | 2.14 Billion EUR | 376.18% |
2020 Q1 | 519.46 Million EUR | -75.05% |
2020 Q2 | 2.17 Billion EUR | 319.57% |
2020 FY | 2.07 Billion EUR | -0.22% |
2020 Q4 | 2.07 Billion EUR | 300.0% |
2020 Q3 | 519.46 Million EUR | -76.17% |
2019 Q1 | 520.6 Million EUR | -68.3% |
2019 FY | 2.08 Billion EUR | 26.8% |
2019 Q4 | 2.08 Billion EUR | 300.0% |
2019 Q3 | 520.6 Million EUR | -71.0% |
2019 Q2 | 1.79 Billion EUR | 244.79% |
2018 Q1 | 410.55 Million EUR | -73.32% |
2018 Q2 | 1.75 Billion EUR | 327.95% |
2018 Q3 | 410.55 Million EUR | -76.63% |
2018 Q4 | 1.64 Billion EUR | 300.0% |
2018 FY | 1.64 Billion EUR | 6.72% |
2017 Q1 | 384.69 Million EUR | -75.0% |
2017 Q3 | 384.69 Million EUR | -75.8% |
2017 Q2 | 1.58 Billion EUR | 313.25% |
2017 FY | 1.53 Billion EUR | -0.02% |
2017 Q4 | 1.53 Billion EUR | 300.0% |
2016 Q1 | 384.76 Million EUR | -72.73% |
2016 Q4 | 1.53 Billion EUR | 300.0% |
2016 Q3 | 384.76 Million EUR | -73.61% |
2016 Q2 | 1.45 Billion EUR | 278.94% |
2016 FY | 1.53 Billion EUR | 9.1% |
2015 Q3 | 352.69 Million EUR | -73.82% |
2015 Q1 | 352.69 Million EUR | -72.62% |
2015 Q2 | 1.34 Billion EUR | 282.03% |
2015 Q4 | 1.41 Billion EUR | 300.0% |
2015 FY | 1.41 Billion EUR | 9.51% |
2014 FY | 1.28 Billion EUR | 23.35% |
2014 Q2 | 1.12 Billion EUR | 250.74% |
2014 Q4 | 1.28 Billion EUR | 300.0% |
2014 Q1 | 322.06 Million EUR | -69.16% |
2014 Q3 | 322.06 Million EUR | -71.49% |
2013 Q1 | 261.1 Million EUR | -74.86% |
2013 Q4 | 1.04 Billion EUR | 300.0% |
2013 Q3 | 261.1 Million EUR | -74.8% |
2013 Q2 | 1.03 Billion EUR | 296.83% |
2013 FY | 1.04 Billion EUR | 0.56% |
2012 FY | 1.03 Billion EUR | -7.45% |
2012 Q1 | 259.64 Million EUR | -76.86% |
2012 Q2 | 1.05 Billion EUR | 305.33% |
2012 Q3 | 259.64 Million EUR | -75.33% |
2012 Q4 | 1.03 Billion EUR | 300.0% |
2011 FY | 1.12 Billion EUR | -12.17% |
2011 Q4 | 1.12 Billion EUR | 300.0% |
2011 Q3 | 280.53 Million EUR | -75.46% |
2011 Q2 | 1.14 Billion EUR | 307.51% |
2011 Q1 | 280.53 Million EUR | -78.04% |
2010 Q4 | 1.27 Billion EUR | 300.0% |
2010 FY | 1.27 Billion EUR | -7.84% |
2010 Q1 | 319.39 Million EUR | -76.96% |
2010 Q2 | 1.5 Billion EUR | 370.74% |
2010 Q3 | 319.39 Million EUR | -78.76% |
2009 Q2 | 346.57 Million EUR | 0.0% |
2009 FY | 1.38 Billion EUR | -36.82% |
2009 Q1 | 346.57 Million EUR | -36.82% |
2009 Q4 | 1.38 Billion EUR | 300.0% |
2009 Q3 | 346.57 Million EUR | 0.0% |
2008 Q3 | 548.55 Million EUR | 0.0% |
2008 Q2 | 548.55 Million EUR | 0.0% |
2008 Q1 | 548.55 Million EUR | 1.9% |
2008 FY | 2.19 Billion EUR | 1.9% |
2008 Q4 | 548.55 Million EUR | 0.0% |
2007 Q2 | 538.31 Million EUR | 0.0% |
2007 Q4 | 538.31 Million EUR | 0.0% |
2007 Q3 | 538.31 Million EUR | 0.0% |
2007 FY | 2.15 Billion EUR | 0.09% |
2007 Q1 | 538.31 Million EUR | 0.09% |
2006 Q2 | 537.81 Million EUR | 0.0% |
2006 Q1 | 537.81 Million EUR | 13.77% |
2006 Q3 | 537.81 Million EUR | 0.0% |
2006 Q4 | 537.81 Million EUR | 0.0% |
2006 FY | 2.15 Billion EUR | 13.77% |
2005 Q2 | 472.71 Million EUR | 0.0% |
2005 Q4 | 472.71 Million EUR | 0.0% |
2005 Q3 | 472.71 Million EUR | 0.0% |
2005 Q1 | 472.71 Million EUR | 59.23% |
2005 FY | 1.89 Billion EUR | 59.23% |
2004 Q2 | 296.87 Million EUR | 0.0% |
2004 Q4 | 296.87 Million EUR | 0.0% |
2004 Q3 | 296.87 Million EUR | 0.0% |
2004 Q1 | 296.87 Million EUR | 0.0% |
2004 FY | 1.18 Billion EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Naturhouse Health, S.A. | 18.21 Million EUR | -8956.344% |
Deoleo, S.A. | 361.68 Million EUR | -356.044% |